Delivery Order SPE2DR25D3021-SPE2DR26FS8PR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 units) on April 24, 2025, with a ceiling value of $12,746.53. This competitive award, utilizing firm fixed pricing, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $9,363.11 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on December 5, 2025, with a completion deadline of December 8, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $8,501.91 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packages) on December 10, 2025, with completion expected by December 11, 2025. This firm fixed-price, competitively awarded contract with no set-aside designation will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,296.38 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packaging). This is a firm fixed-price delivery order with no set-aside designation, awarded on May 16, 2025, with an ultimate completion date of May 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of NURTEC ODT 75 mg tablets (8-pack quantity) valued at $14,310.29 under a firm fixed price contract. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a delivery order valued at $7,470.55 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (quantity 8) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award, utilizing firm fixed-price pricing, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $105,724.99 under a firm fixed price contract. The award, made on December 16, 2025, represents a non-competitive delivery against AmerisourceBergen's larger pharmaceutical supply agreement with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $10,977.91 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on September 15, 2025, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The...
- The Defense Logistics Agency awarded a delivery order valued at $3,884.63 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 13, 2025, with completion scheduled for November 14, 2025. This non-competitive delivery order represents a firm fixed price transaction sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- SPE2DR25D3021Indefinite Delivery Contract
- SPE2DR25D3021-SPE2DR26FS8PRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,373.75 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on December 15, 2025, with an ultimate completion date of December 16, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that supports pharmaceutical supply needs across the Defense Health Agency and other federal healthcare systems. NURTEC ODT is a migraine treatment medication, and this delivery order reflects AmerisourceBergen's role as a critical pharmaceutical distributor for military and federal medical procurement. As a major pharmaceutical and healthcare solutions provider, AmerisourceBergen has demonstrated capability to fulfill federal medical supply requirements through competitive procurement processes. The company maintains an extensive portfolio of pharmaceutical deliveries to DLA spanning multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies that support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 12/14/25 |